Contractor profile

Mapp Biopharmaceutical, Inc.

FY2022 · complete year · data as of 2026-07-11

No FY2026 activity recorded for this recipient. Showing FY2022, its most recent year with data.

prime recipient of federal awards · UEI M9V9QTHR1H28 Source
$225.6M
Obligated
FY2022
2
Funding agencies
100%
From Health and Hum…
0%
Non-competed
2
States
97%
In California
5
Industries

In FY2022, Mapp Biopharmaceutical, Inc. received $225.6M in federal awards from 2 agencies, 100% of it from the Department of Health and Human Services, with 97% of the work performed in California. Computed

Where this money comes from

Source
FUNDING AGENCIES
MAPP BIOPHARMACEUTICAL,
HHS
$0.2B
1 other agencies
$0B
Mapp Biopharmaceutical, Inc.
$0.2B
FY2022 obligated
band width = obligations · FY2022 · source: USASpending.gov

Where the work lands

Source
California$218.2M
Maryland$88.8K

State breakdown available for 96% of obligations shown

Key takeaways

Computed
FY2022 · complete year · data as of 2026-07-11
  • Mapp Biopharmaceutical, Inc. received $225.6M in federal obligations in FY2022.
  • The Department of Health and Human Services accounted for 99% of it.
  • Its largest recorded industry was Research and Development in Biotechnology (except Nanobiotechnology), at $205.2M.
  • California was its largest place of performance, with 96% of the work.

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2022, by the amount obligated on each so far.

No award on record was active in FY2022.

Largest FY2022 awards

Awards that started in FY2022, by the amount obligated on each so far.

No award on record started in FY2022.

What it does (NAICS / PSC)

Research and Development in Biotechnology (except Nanobiotechnology)$205.2M
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$15.5M
Research and Development in the Social Sciences and Humanities$3.3M
Scientific Research - Combating Weapons of Mass Destruction$335.4K
Research and Development in Biotechnology$194.3K
Testing Laboratories and Services$88.8K

Competition

0%non-competed (often called no-bid), of $217M in contract obligations in FY2022Computed

This describes how contracts were awarded, not wrongdoing.

Corporate family

Single registration: no combined family.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.